Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases
Description
Asthma, lung cancer, cystic fibrosis, tuberculosis, acute respiratory distress syndrome, chronic obstructive pulmonary disease, and COVID-19 are few examples of inflammatory lung conditions that cause cytokine release syndrome. It can initiate a